Peripherally Inserted Central Catheter (PICC) Devices -Market Insights, Competitive Landscape and Market Forecast–2026
This report can be delivered to the clients within 7-10 Business Days
Peripherally Inserted Central Catheters (PICC) Market By Product Type (Power Injected Peripherally Inserted Central Catheters, Non-Power Injected/Conventional Peripherally Inserted Central Catheters), By Design (Single Lumen, Double Lumen, Triple Lumen), By End User (Hospitals, Ambulatory Surgical Centers, And Others), By Geography is anticipated to expand at a static CAGR forecast till 2026 owing to increase in incidence of cancer and introduction of products that are technologically advanced to reduce complications associated with PICCS.
Global Peripherally Inserted Central Catheters (PICC) Market was valued at USD 878.5 million in 2020, growing at a CAGR of 5.23% during the forecast period from 2021 to 2026 to reach USD 1188.52 million by 2026. The rise in demand for Peripherally Inserted Central Catheters (PICC) is predominantly attributed to the rising incidence of cancer, infectious diseases, among others disorders which require application of these catheters; growing demand for PICC due to increase in prolonged treatment with antibiotics, transfusions, oncologic IV therapy and total parental nutrition. In addition, advantages of PICC catheters compared to needle stick for blood sample withdrawal, integration of advanced technologies to the existing products to prevent complication and risk associated with its usage, and new product launches could also boost the market.
Peripherally Inserted Central Catheters (PICC) Market Dynamics:
Rising incidence of cancer across the globe has increased the demand for peripherally inserted central catheters (PICC). This is because PICC are used to administer chemotherapy drugs directly into the veins and avoid irritation in the veins. According to the Global Cancer Observatory (GLOBOCAN) 2021 report, there were approximately 19,292,789 cases of cancer worldwide in the year 2020. In addition, increase in sedentary lifestyle such as tobacco use, alcohol use, unhealthy diet, physical inactivity are risk factors for cancer (and other noncommunicable diseases) and can cause rise in carcinoma cases. As per the study: Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study by Rumgay H., et al. published in the LANCET in the year 2021, an estimated 741?300 of all new cancer cases in the year 2020 were due to alcohol consumption. Thus, this can be a potential factor driving the PICC market.
Moreover, increase in parentral nutrition for the patients suffering from variety of disorders or conditions that impair food intake, nutrient digestion or absorption is also anticipated to increase the demand for peripherally inserted central catheters.
Additionally, recent product approval of PICC is also expected to contribute to the growth of global PICC market. For instance, recently in April 2020, Biowy Corporation received FDA approval for its Biowy PICC Catheter S Kit indicated for short or long term peripheral access to the central venous system for intravenous therapy and power injection of contrast media as well as for blood sampling, infusion or therapy.
Hence, all the aforementioned factors is projected to contribute to the global PICC market.
However, increase in prevalence of deep vein thrombosis, and high risk of bloodstream infections are some of the factors that are likely to impede the PICC market growth.
Peripherally Inserted Central Catheters (PICC) Segment Analysis:
Peripherally Inserted Central Catheters (PICC) Market By Product Type (Power Injected Peripherally Inserted Central Catheters, Non-Power Injected/Conventional Peripherally Inserted Central Catheters), By Design (Single Lumen, Double Lumen, Triple Lumen), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Peripherally Inserted Central Catheters (PICC) product segment, the power injected peripherally inserted central catheters are expected to hold the largest market share during the forecasted period. This is owing to the advantages that are asscociated with power PICC. For instance most of the power PICC are made of polyurethane, a stronger material which can withstand the pressures with only a small decrease in flexibility rather than silicone like in conventional PICC. In addition, Power-injectable PICCs also have many advantages in the ICU such as they can be used as multipurpose central lines for any type of infusion including hemodynamic monitoring, for high-flow infusion, and for high-pressure injection of contrast media during radiological procedures.
Furthermore, integration of antimicrobial and antithrombogenic technology with the power injected PICC is also anticipated to augment the market. For instance, Pressure Injectable Arrowg+ard Blue Advance One-Lumen PICC pre-loaded with Arrow VPS Precision Stylet has antimicrobial and antithrombogenic property for lesser complications and risk.
Thus, these factors are projected to bolster the demand for power PICC thereby increasing the segmental market of PICC.
North America is expected to dominate the overall Peripherally Inserted Central Catheters (PICC) Market:
Among all the countries, North America is anticipated to dominate the overall Peripherally Inserted Central Catheters (PICC) market during the forecast period. This domination is due to the favorurbale reimbursement scenario, well established guideines for PICC use in the region along with presence of enhanced and advanced healthcare facility.
Furher, In the United States, the rising cases of chronic disorder such as cancer, respiratory disorders, gastrointestinal disorder in the region is likely to increase the demand for PICC. For instance according to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF) a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States. In addition, people suffering with cystic fibrosis who need intravenous (IV) antibiotic treatments for more than just a few days, such as during an exacerbation could potentially raise the demand for PICC catheters.
Also, rise in hospital enrolment due to surge in infectious diseses that require administration of antibiotics in the veins will also contribute to the PICC market growth. For instance, increasing COVID-19 cases and growing hospital admission in the region such as per a study: Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021 published in Center for Disease Control and Prevention in the year 2021, at selected hospitals, the number of COVID-19 patients aged 0–17 years who were admitted to an ICU ranged from 10% to 25% during August 2020–June 2021 and was 20% and 18% during July and August 2021, respectively. Thus, it can also be a driving factor for the PICC market.
Moreover, presence of key market players such as Cook, AngioDynamics, and Becton, Dickinson and Company, among others is also projected to augment the market for PICC.
Hence all the above mentioned is expected to grow the regional market for Peripherally Inserted Central Catheters (PICC).
Also, the Asia-Pacific region have the future potential growth for the Global PICC catheters. Rising cases of infectious diseases, high hospital admission, increase in disposable income, rapid urbanization, and improving healthcare facilities are the factors that are likely to drive the market.
Peripherally Inserted Central Catheters (PICC) Market Key Players:
Some of the key market players operating in the Peripherally Inserted Central Catheters (PICC) market include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de Mйxico, S.A. de C.V, Healthline Medical Products, and others.
Recent Developmental Activities in the Peripherally Inserted Central Catheters (PICC) Market:
In Januray 2020, AngioDynamics Inc. acquired the C3 Wave PICC tip location system from Medical Components Inc.
In February 2020, Access Vascular, Inc received the US FDA approval for HydroPICC a peripherally inserted central catheter (PICC) intended for short or long-term use.
Key Takeaways from the Peripherally Inserted Central Catheters (PICC) Market Report Study
Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Peripherally Inserted Central Catheters (PICC) market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Peripherally Inserted Central Catheters (PICC) Market.
Various opportunities available for the other competitor in the Peripherally Inserted Central Catheters (PICC) Market space.
What are the top-performing segments in 2020? How these segments will perform in 2026.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Peripherally Inserted Central Catheters (PICC) market growth in the coming future?
Target Audience who can be benefited from the Peripherally Inserted Central Catheters (PICC) Market Report Study
Peripherally Inserted Central Catheters (PICC) providers
Research organizations and consulting companies
Peripherally Inserted Central Catheters (PICC)-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Peripherally Inserted Central Catheters (PICC)
Various End-users who want to know more about the Peripherally Inserted Central Catheters (PICC) Market and the latest technological developments in the Peripherally Inserted Central Catheters (PICC) market.
Frequently Asked Questions for the Peripherally Inserted Central Catheters (PICC) Market:
1. What are Peripherally Inserted Central Catheters (PICC)?
A Peripherally Inserted Central Catheter (PICC) is a thin and flexible tube which is inserted into a vein to give intravenous fluids, blood transfusions, chemotherapy, and other drugs.
2. What is the market for Global Peripherally Inserted Central Catheters (PICC)?
Global Peripherally Inserted Central Catheters (PICC) Market was valued at USD 878.5 million in 2020, growing at a CAGR of 5.23% during the forecast period from 2021 to 2026 to reach USD 1188.52 million by 2026.
3. What are the drivers for Global Peripherally Inserted Central Catheters (PICC)?
The major factors driving the demand for Peripherally Inserted Central Catheters (PICC) are the rising incidence of cancer, infectious diseases; growing demand for PICC due to increase in prolonged treatment with antibiotics, transfusions, oncologic IV therapy and total parental nutrition, and advances in product portfolio, among others.
4. What are the key players operating in Global Peripherally Inserted Central Catheters (PICC)?
Some of the key market players operating in the Peripherally Inserted Central Catheters (PICC) market include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de Mйxico, S.A. de C.V, Healthline Medical Products, and others.
5. Which region has the highest share in Peripherally Inserted Central Catheters (PICC) Market?
North America is anticipated to dominate the overall Peripherally Inserted Central Catheters (PICC) market during the forecast period 2021-2026. This domination is due to favorurbale reimbursement scenario, well established guideines for PICC use in the region along with presence of enhanced and advanced healthcare facility.
Peripherally Inserted Central Catheters (PICC) Market By Product Type (Power Injected Peripherally Inserted Central Catheters, Non-Power Injected/Conventional Peripherally Inserted Central Catheters), By Design (Single Lumen, Double Lumen, Triple Lumen), By End User (Hospitals, Ambulatory Surgical Centers, And Others), By Geography is anticipated to expand at a static CAGR forecast till 2026 owing to increase in incidence of cancer and introduction of products that are technologically advanced to reduce complications associated with PICCS.
Global Peripherally Inserted Central Catheters (PICC) Market was valued at USD 878.5 million in 2020, growing at a CAGR of 5.23% during the forecast period from 2021 to 2026 to reach USD 1188.52 million by 2026. The rise in demand for Peripherally Inserted Central Catheters (PICC) is predominantly attributed to the rising incidence of cancer, infectious diseases, among others disorders which require application of these catheters; growing demand for PICC due to increase in prolonged treatment with antibiotics, transfusions, oncologic IV therapy and total parental nutrition. In addition, advantages of PICC catheters compared to needle stick for blood sample withdrawal, integration of advanced technologies to the existing products to prevent complication and risk associated with its usage, and new product launches could also boost the market.
Peripherally Inserted Central Catheters (PICC) Market Dynamics:
Rising incidence of cancer across the globe has increased the demand for peripherally inserted central catheters (PICC). This is because PICC are used to administer chemotherapy drugs directly into the veins and avoid irritation in the veins. According to the Global Cancer Observatory (GLOBOCAN) 2021 report, there were approximately 19,292,789 cases of cancer worldwide in the year 2020. In addition, increase in sedentary lifestyle such as tobacco use, alcohol use, unhealthy diet, physical inactivity are risk factors for cancer (and other noncommunicable diseases) and can cause rise in carcinoma cases. As per the study: Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study by Rumgay H., et al. published in the LANCET in the year 2021, an estimated 741?300 of all new cancer cases in the year 2020 were due to alcohol consumption. Thus, this can be a potential factor driving the PICC market.
Moreover, increase in parentral nutrition for the patients suffering from variety of disorders or conditions that impair food intake, nutrient digestion or absorption is also anticipated to increase the demand for peripherally inserted central catheters.
Additionally, recent product approval of PICC is also expected to contribute to the growth of global PICC market. For instance, recently in April 2020, Biowy Corporation received FDA approval for its Biowy PICC Catheter S Kit indicated for short or long term peripheral access to the central venous system for intravenous therapy and power injection of contrast media as well as for blood sampling, infusion or therapy.
Hence, all the aforementioned factors is projected to contribute to the global PICC market.
However, increase in prevalence of deep vein thrombosis, and high risk of bloodstream infections are some of the factors that are likely to impede the PICC market growth.
Peripherally Inserted Central Catheters (PICC) Segment Analysis:
Peripherally Inserted Central Catheters (PICC) Market By Product Type (Power Injected Peripherally Inserted Central Catheters, Non-Power Injected/Conventional Peripherally Inserted Central Catheters), By Design (Single Lumen, Double Lumen, Triple Lumen), By End User (Hospitals, Ambulatory Surgical Centers, and Others), and by Geography (North America, Europe, Asia-Pacific, and Rest of the World).
In the Peripherally Inserted Central Catheters (PICC) product segment, the power injected peripherally inserted central catheters are expected to hold the largest market share during the forecasted period. This is owing to the advantages that are asscociated with power PICC. For instance most of the power PICC are made of polyurethane, a stronger material which can withstand the pressures with only a small decrease in flexibility rather than silicone like in conventional PICC. In addition, Power-injectable PICCs also have many advantages in the ICU such as they can be used as multipurpose central lines for any type of infusion including hemodynamic monitoring, for high-flow infusion, and for high-pressure injection of contrast media during radiological procedures.
Furthermore, integration of antimicrobial and antithrombogenic technology with the power injected PICC is also anticipated to augment the market. For instance, Pressure Injectable Arrowg+ard Blue Advance One-Lumen PICC pre-loaded with Arrow VPS Precision Stylet has antimicrobial and antithrombogenic property for lesser complications and risk.
Thus, these factors are projected to bolster the demand for power PICC thereby increasing the segmental market of PICC.
North America is expected to dominate the overall Peripherally Inserted Central Catheters (PICC) Market:
Among all the countries, North America is anticipated to dominate the overall Peripherally Inserted Central Catheters (PICC) market during the forecast period. This domination is due to the favorurbale reimbursement scenario, well established guideines for PICC use in the region along with presence of enhanced and advanced healthcare facility.
Furher, In the United States, the rising cases of chronic disorder such as cancer, respiratory disorders, gastrointestinal disorder in the region is likely to increase the demand for PICC. For instance according to the Centre for Disease Control and Prevention (CDC) 2020, Cystic fibrosis (CF) a genetic disorder that causes problems with breathing and digestion affects about 35,000 people in the United States. In addition, people suffering with cystic fibrosis who need intravenous (IV) antibiotic treatments for more than just a few days, such as during an exacerbation could potentially raise the demand for PICC catheters.
Also, rise in hospital enrolment due to surge in infectious diseses that require administration of antibiotics in the veins will also contribute to the PICC market growth. For instance, increasing COVID-19 cases and growing hospital admission in the region such as per a study: Trends in COVID-19 Cases, Emergency Department Visits, and Hospital Admissions Among Children and Adolescents Aged 0–17 Years — United States, August 2020–August 2021 published in Center for Disease Control and Prevention in the year 2021, at selected hospitals, the number of COVID-19 patients aged 0–17 years who were admitted to an ICU ranged from 10% to 25% during August 2020–June 2021 and was 20% and 18% during July and August 2021, respectively. Thus, it can also be a driving factor for the PICC market.
Moreover, presence of key market players such as Cook, AngioDynamics, and Becton, Dickinson and Company, among others is also projected to augment the market for PICC.
Hence all the above mentioned is expected to grow the regional market for Peripherally Inserted Central Catheters (PICC).
Also, the Asia-Pacific region have the future potential growth for the Global PICC catheters. Rising cases of infectious diseases, high hospital admission, increase in disposable income, rapid urbanization, and improving healthcare facilities are the factors that are likely to drive the market.
Peripherally Inserted Central Catheters (PICC) Market Key Players:
Some of the key market players operating in the Peripherally Inserted Central Catheters (PICC) market include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de Mйxico, S.A. de C.V, Healthline Medical Products, and others.
Recent Developmental Activities in the Peripherally Inserted Central Catheters (PICC) Market:
In Januray 2020, AngioDynamics Inc. acquired the C3 Wave PICC tip location system from Medical Components Inc.
In February 2020, Access Vascular, Inc received the US FDA approval for HydroPICC a peripherally inserted central catheter (PICC) intended for short or long-term use.
Key Takeaways from the Peripherally Inserted Central Catheters (PICC) Market Report Study
Market size analysis for current market size (2020), and market forecast for 5 years (2021-2026)
The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Peripherally Inserted Central Catheters (PICC) market.
Top key product/services/technology developments, merger, acquisition, partnership, joint venture happened for last 3 years
Key companies dominating the Global Peripherally Inserted Central Catheters (PICC) Market.
Various opportunities available for the other competitor in the Peripherally Inserted Central Catheters (PICC) Market space.
What are the top-performing segments in 2020? How these segments will perform in 2026.
Which are the top-performing regions and countries in the current market scenario?
Which are the regions and countries where companies should have concentrated on opportunities for Peripherally Inserted Central Catheters (PICC) market growth in the coming future?
Target Audience who can be benefited from the Peripherally Inserted Central Catheters (PICC) Market Report Study
Peripherally Inserted Central Catheters (PICC) providers
Research organizations and consulting companies
Peripherally Inserted Central Catheters (PICC)-related organization, association, forum, and other alliances
Government and corporate offices
Start-up companies, venture capitalists, and private equity firms
Distributors and Traders in Peripherally Inserted Central Catheters (PICC)
Various End-users who want to know more about the Peripherally Inserted Central Catheters (PICC) Market and the latest technological developments in the Peripherally Inserted Central Catheters (PICC) market.
Frequently Asked Questions for the Peripherally Inserted Central Catheters (PICC) Market:
1. What are Peripherally Inserted Central Catheters (PICC)?
A Peripherally Inserted Central Catheter (PICC) is a thin and flexible tube which is inserted into a vein to give intravenous fluids, blood transfusions, chemotherapy, and other drugs.
2. What is the market for Global Peripherally Inserted Central Catheters (PICC)?
Global Peripherally Inserted Central Catheters (PICC) Market was valued at USD 878.5 million in 2020, growing at a CAGR of 5.23% during the forecast period from 2021 to 2026 to reach USD 1188.52 million by 2026.
3. What are the drivers for Global Peripherally Inserted Central Catheters (PICC)?
The major factors driving the demand for Peripherally Inserted Central Catheters (PICC) are the rising incidence of cancer, infectious diseases; growing demand for PICC due to increase in prolonged treatment with antibiotics, transfusions, oncologic IV therapy and total parental nutrition, and advances in product portfolio, among others.
4. What are the key players operating in Global Peripherally Inserted Central Catheters (PICC)?
Some of the key market players operating in the Peripherally Inserted Central Catheters (PICC) market include AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated., Argon Medical Devices, Inc., Cook, Theragenics Corporation, ICU Medical, Inc., Medical Components, Inc., Access Vascular, Vygon, Biowy Corporation, Polymedicure, Footprint Medical Inc., Novamed Medical Systems, INSUNG MEDICAL Co., Ltd., SILMAG, pfm medical ag, Equipos de Biomedicina de Mйxico, S.A. de C.V, Healthline Medical Products, and others.
5. Which region has the highest share in Peripherally Inserted Central Catheters (PICC) Market?
North America is anticipated to dominate the overall Peripherally Inserted Central Catheters (PICC) market during the forecast period 2021-2026. This domination is due to favorurbale reimbursement scenario, well established guideines for PICC use in the region along with presence of enhanced and advanced healthcare facility.
1.PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) REPORT INTRODUCTION
2. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking
3. REGULATORY AND PATENT ANALYSIS
3.1. The United States
3.2. Europe
3.2.1. Germany
3.2.2. France
3.2.3. Italy
3.2.4. Spain
3.2.5. The U.K.
3.3. Japan
4. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET KEY FACTORS ANALYSIS
4.1. Peripherally Inserted Central Catheters (PICC) Market Drivers
4.1.1. Increasing incidence of cancer, infectious diseases, among others
4.1.2. Technological Advancement in the product portfolio
4.1.3. Proper reimbursement
4.1.4. New Product Approval & launches
4.2. Peripherally Inserted Central Catheters (PICC) Market Restraints and Challenges
4.2.1. Complication associated with the PICC
4.2.2. Fewer Product Recalls
4.3. Peripherally Inserted Central Catheters (PICC) Market Opportunities
4.3.1. Growth opportunities in hydrophobic polyurethane PICC
4.3.2. Growth opportunities in the emerging nation
5. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET
7. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET LAYOUT
7.1. By Product Type
7.1.1. Power Injected Peripherally Inserted Central Catheters
7.1.2. Non- Power Injected/Conventional Peripherally Inserted Central Catheters
7.2. By Design
7.2.1. Single Lumen
7.2.2. Double Lumen
7.2.3. Triple Lumen
7.3. By End User
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. By Geography
7.4.1. North America
7.4.1.1. North America Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.1.2. North America Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.1.3. North America Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.1.4. North America Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.1.4.1. United States
7.4.1.4.2. Canada
7.4.1.4.3. Mexico
7.4.2. Europe
7.4.2.1. Europe Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.2.2. Europe Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.2.3. Europe Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.2.4. Europe Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.2.4.1. France
7.4.2.4.2. Germany
7.4.2.4.3. United Kingdom
7.4.2.4.4. Italy
7.4.2.4.5. Spain
7.4.2.4.6. Russia
7.4.2.4.7. Rest of Europe
7.4.3. Asia-Pacific
7.4.3.1. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.3.2. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.3.3. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.3.4. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.3.4.1. China
7.4.3.4.2. Japan
7.4.3.4.3. India
7.4.3.4.4. Australia
7.4.3.4.5. South Korea
7.4.3.4.6. Rest of Asia Pacific
7.4.4. Rest of the World (RoW)
7.4.4.1. RoW Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.4.2. RoW Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.4.3. RoW Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.4.4. RoW Peripherally Inserted Central Catheters (PICC) Market, by Region
7.4.4.4.1. Middle East
7.4.4.4.2. Africa
7.4.4.4.3. South America
8. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES
9. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) COMPANY AND PRODUCT PROFILES
9.1. AngioDynamics
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. BD
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. Teleflex Incorporated
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. ARGON MEDICAL
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Cook
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. ICU Medical, Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Medical Components, Inc.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. Access Vascular
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Vygon
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. Theragenics Corporation
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Biowy Corporation
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Polymedicure
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. Footprint Medical Inc.
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. Novamed Medical Systems
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. INSUNG MEDICAL Co., Ltd.
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. SILMAG
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. pfm medical ag
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. Equipos de Biomedicina de Mйxico, S.A. de C.V
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
9.20. Healthline Medical Products
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Financial Overview
9.20.4. Product Listing
9.20.5. Entropy
10. PROJECT APPROACH
10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions
11. KOL VIEWS
12. DELVEINSIGHT CAPABILITIES
13. DISCLAIMER
14. ABOUT DELVEINSIGHT
2. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) EXECUTIVE SUMMARY
2.1. Scope of the Study
2.2. Market at Glance
2.3. Competitive Assessment
2.4. Financial Benchmarking
3. REGULATORY AND PATENT ANALYSIS
3.1. The United States
3.2. Europe
3.2.1. Germany
3.2.2. France
3.2.3. Italy
3.2.4. Spain
3.2.5. The U.K.
3.3. Japan
4. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET KEY FACTORS ANALYSIS
4.1. Peripherally Inserted Central Catheters (PICC) Market Drivers
4.1.1. Increasing incidence of cancer, infectious diseases, among others
4.1.2. Technological Advancement in the product portfolio
4.1.3. Proper reimbursement
4.1.4. New Product Approval & launches
4.2. Peripherally Inserted Central Catheters (PICC) Market Restraints and Challenges
4.2.1. Complication associated with the PICC
4.2.2. Fewer Product Recalls
4.3. Peripherally Inserted Central Catheters (PICC) Market Opportunities
4.3.1. Growth opportunities in hydrophobic polyurethane PICC
4.3.2. Growth opportunities in the emerging nation
5. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) PORTER’S FIVE FORCES ANALYSIS
5.1. Bargaining Power of Suppliers
5.2. Bargaining Power of Consumers
5.3. Threat of New Entrants
5.4. Threat of Substitutes
5.5. Competitive Rivalry
6. COVID-19 IMPACT ANALYSIS ON PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET
7. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) MARKET LAYOUT
7.1. By Product Type
7.1.1. Power Injected Peripherally Inserted Central Catheters
7.1.2. Non- Power Injected/Conventional Peripherally Inserted Central Catheters
7.2. By Design
7.2.1. Single Lumen
7.2.2. Double Lumen
7.2.3. Triple Lumen
7.3. By End User
7.3.1. Hospitals
7.3.2. Ambulatory Surgical Centers
7.3.3. Others
7.4. By Geography
7.4.1. North America
7.4.1.1. North America Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.1.2. North America Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.1.3. North America Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.1.4. North America Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.1.4.1. United States
7.4.1.4.2. Canada
7.4.1.4.3. Mexico
7.4.2. Europe
7.4.2.1. Europe Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.2.2. Europe Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.2.3. Europe Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.2.4. Europe Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.2.4.1. France
7.4.2.4.2. Germany
7.4.2.4.3. United Kingdom
7.4.2.4.4. Italy
7.4.2.4.5. Spain
7.4.2.4.6. Russia
7.4.2.4.7. Rest of Europe
7.4.3. Asia-Pacific
7.4.3.1. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.3.2. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.3.3. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.3.4. Asia-Pacific Peripherally Inserted Central Catheters (PICC) Market, by Country
7.4.3.4.1. China
7.4.3.4.2. Japan
7.4.3.4.3. India
7.4.3.4.4. Australia
7.4.3.4.5. South Korea
7.4.3.4.6. Rest of Asia Pacific
7.4.4. Rest of the World (RoW)
7.4.4.1. RoW Peripherally Inserted Central Catheters (PICC) Market, by Product Type
7.4.4.2. RoW Peripherally Inserted Central Catheters (PICC) Market, by Design
7.4.4.3. RoW Peripherally Inserted Central Catheters (PICC) Market, by End User
7.4.4.4. RoW Peripherally Inserted Central Catheters (PICC) Market, by Region
7.4.4.4.1. Middle East
7.4.4.4.2. Africa
7.4.4.4.3. South America
8. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) GLOBAL COMPANY SHARE ANALYSIS – KEY 3-5 COMPANIES
9. PERIPHERALLY INSERTED CENTRAL CATHETERS (PICC) COMPANY AND PRODUCT PROFILES
9.1. AngioDynamics
9.1.1. Company Overview
9.1.2. Company Snapshot
9.1.3. Financial Overview
9.1.4. Product Listing
9.1.5. Entropy
9.2. B. Braun Melsungen AG
9.2.1. Company Overview
9.2.2. Company Snapshot
9.2.3. Financial Overview
9.2.4. Product Listing
9.2.5. Entropy
9.3. BD
9.3.1. Company Overview
9.3.2. Company Snapshot
9.3.3. Financial Overview
9.3.4. Product Listing
9.3.5. Entropy
9.4. Teleflex Incorporated
9.4.1. Company Overview
9.4.2. Company Snapshot
9.4.3. Financial Overview
9.4.4. Product Listing
9.4.5. Entropy
9.5. ARGON MEDICAL
9.5.1. Company Overview
9.5.2. Company Snapshot
9.5.3. Financial Overview
9.5.4. Product Listing
9.5.5. Entropy
9.6. Cook
9.6.1. Company Overview
9.6.2. Company Snapshot
9.6.3. Financial Overview
9.6.4. Product Listing
9.6.5. Entropy
9.7. ICU Medical, Inc.
9.7.1. Company Overview
9.7.2. Company Snapshot
9.7.3. Financial Overview
9.7.4. Product Listing
9.7.5. Entropy
9.8. Medical Components, Inc.
9.8.1. Company Overview
9.8.2. Company Snapshot
9.8.3. Financial Overview
9.8.4. Product Listing
9.8.5. Entropy
9.9. Access Vascular
9.9.1. Company Overview
9.9.2. Company Snapshot
9.9.3. Financial Overview
9.9.4. Product Listing
9.9.5. Entropy
9.10. Vygon
9.10.1. Company Overview
9.10.2. Company Snapshot
9.10.3. Financial Overview
9.10.4. Product Listing
9.10.5. Entropy
9.11. Theragenics Corporation
9.11.1. Company Overview
9.11.2. Company Snapshot
9.11.3. Financial Overview
9.11.4. Product Listing
9.11.5. Entropy
9.12. Biowy Corporation
9.12.1. Company Overview
9.12.2. Company Snapshot
9.12.3. Financial Overview
9.12.4. Product Listing
9.12.5. Entropy
9.13. Polymedicure
9.13.1. Company Overview
9.13.2. Company Snapshot
9.13.3. Financial Overview
9.13.4. Product Listing
9.13.5. Entropy
9.14. Footprint Medical Inc.
9.14.1. Company Overview
9.14.2. Company Snapshot
9.14.3. Financial Overview
9.14.4. Product Listing
9.14.5. Entropy
9.15. Novamed Medical Systems
9.15.1. Company Overview
9.15.2. Company Snapshot
9.15.3. Financial Overview
9.15.4. Product Listing
9.15.5. Entropy
9.16. INSUNG MEDICAL Co., Ltd.
9.16.1. Company Overview
9.16.2. Company Snapshot
9.16.3. Financial Overview
9.16.4. Product Listing
9.16.5. Entropy
9.17. SILMAG
9.17.1. Company Overview
9.17.2. Company Snapshot
9.17.3. Financial Overview
9.17.4. Product Listing
9.17.5. Entropy
9.18. pfm medical ag
9.18.1. Company Overview
9.18.2. Company Snapshot
9.18.3. Financial Overview
9.18.4. Product Listing
9.18.5. Entropy
9.19. Equipos de Biomedicina de Mйxico, S.A. de C.V
9.19.1. Company Overview
9.19.2. Company Snapshot
9.19.3. Financial Overview
9.19.4. Product Listing
9.19.5. Entropy
9.20. Healthline Medical Products
9.20.1. Company Overview
9.20.2. Company Snapshot
9.20.3. Financial Overview
9.20.4. Product Listing
9.20.5. Entropy
10. PROJECT APPROACH
10.1. Secondary Sources
10.2. Primary Sources
10.3. Data Triangulation
10.4. Key Expert Opinions
11. KOL VIEWS
12. DELVEINSIGHT CAPABILITIES
13. DISCLAIMER
14. ABOUT DELVEINSIGHT
